Log in to save to my catalogue

Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a d...

Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b29b925c20354f2783efc5cf86448670

Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases

About this item

Full title

Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2022-05, Vol.21 (1), p.82-82, Article 82

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Statin treatment increases the risk of new-onset diabetes mellitus (NODM); however, data directly comparing the risk of NODM among individual statins is limited. We compared the risk of NODM between patients using pitavastatin and atorvastatin or rosuvastatin using reliable, large-scale data.
Data of electronic health records from ten hospitals...

Alternative Titles

Full title

Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b29b925c20354f2783efc5cf86448670

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b29b925c20354f2783efc5cf86448670

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-022-01524-6

How to access this item